Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P44
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.24% |
| Q3 2025 | 9.37% |
| Q2 2025 | 90.16% |
| Q1 2025 | -18070.27% |
| Q4 2024 | 103.90% |
| Q3 2024 | 64.96% |
| Q2 2024 | -121.70% |
| Q1 2024 | 4.68% |
| Q4 2023 | -22.65% |
| Q3 2023 | 4.24% |
| Q2 2023 | 20.66% |
| Q1 2023 | -4.30% |
| Q4 2022 | -9.63% |
| Q3 2022 | -7.81% |
| Q2 2022 | 12.40% |
| Q1 2022 | -17.55% |
| Q4 2021 | -519.11% |
| Q3 2021 | 140.35% |
| Q2 2021 | 53.11% |
| Q1 2021 | -216.68% |
| Q4 2020 | 416.07% |
| Q3 2020 | -2.69% |
| Q2 2020 | -1929.32% |
| Q1 2020 | 1486.81% |
| Q4 2019 | 99.69% |
| Q3 2019 | -18.41% |
| Q2 2019 | 18.89% |
| Q1 2019 | 1.54% |
| Q4 2018 | -22.98% |
| Q3 2018 | -11.11% |
| Q2 2018 | 6.78% |
| Q1 2018 | -16.46% |
| Q4 2017 | 5.72% |
| Q3 2017 | 13.78% |
| Q2 2017 | -7.01% |
| Q1 2017 | -25.42% |
| Q4 2016 | -8.78% |
| Q3 2016 | 5.43% |
| Q2 2016 | 4.41% |
| Q1 2016 | -1273.46% |